Dacarbazine molecule
Brand Names: DTIC-Dome, DTIC, DIC, Imidazole Carboxamide
Dacarbazine is a chemotherapy drug that is administered for the treatment of melanomas, neuroblastoma, and lymphomas. It functions as an alkylating chemotherapy agent, meaning it interferes with DNA reproduction in fast growing cells, thus preventing cell duplication and growth.
This drug is used primarily in the treatment of Hodgkin’s Disease. It is commonly used in conjunction with other chemotherapy drugs in the ABVD treatment regimen (adriamycin, bleomycin, oncovin, dacarbazine).
Drug Administration
Dacarbazine is given intravenously. The injection site should be monitored, as the drug is a known irritant. If any signs of inflammation are observed, a doctor should be alerted immediately.
Side Effects
Common side effects include peripheral neuropathy (numbness or tingling in the hands or feet), flu symptoms, and photosensitivity (sensitivity to light).
There is a small chance of developing leukemia as a secondary cancer, so the doctor should monitor patients after treatment stops.
More Information
Call 1-877-399-5078 Anytime To Discuss Treatment Options
If you or a loved one has been diagnosed with Lymphoma, please call toll-free 1-877-399-5078 for treatment options.
Cancer Support Groups
SupportGroups.com is for individuals, friends and families who are looking to connect during life's challenging times. Share personal experiences, evaluate information and get support during times of need, illness, treatment or recovery.
Find a Treatment Facility Near You
Click on a state below to find Lymphoma treatment options that could be right for you.
For more information on Hodgkin's Lymphoma, please see the following pages:
